Skip to main content
. Author manuscript; available in PMC: 2010 Mar 26.
Published in final edited form as: J Matern Fetal Neonatal Med. 2008 May;21(5):279–287. doi: 10.1080/14767050802034545

Tables V.

Odds ratios for association of the slopes of PlGF/sVEGFR-1, PlGF/s-Eng, PlGF/(s-Eng x sVEGFR-1) ratios and the s-Eng x sVEGFR-1 product between the first and second trimesters with the subsequent development of preterm PE, term PE, and delivery of an SGA neonate

Normal Pregnancy Preterm preeclampsia Term preeclampsia SGA
n n 95%CI n OR 95%CI n OR 95%CI
PlGF/s-Eng slope between the 1st and 2nd trimesters
Below median 101 15 7.68 1.7-34.74 28 2.46 1.15-5.26 86 1.47 0.95-2.26
Above median 100 2 1 Reference 11 1 Reference 59 1 Reference
PlGF/sVEGFR-1 slope between the 1st and 2nd trimesters
Below median 101 13 3.28 1.02-10.59 19 0.83 0.41-1.67 76 1.13 0.73-1.74
Above median 100 4 1 Reference 20 1 Reference 69 1 Reference
PlGF/(s-Eng x sVEGFR-1) slope between the 1st and 2nd trimesters
Below median 100 13 3.71 1.14-12.11 22 1.20 0.59-2.45 71 0.99 0.64-1.53
Above median 101 4 1 Reference 17 1 Reference 74 1 Reference
s-Eng x sVEGFR-1 direction of change between the 1st and 2nd trimesters
≤ 0 151 4 1 Reference 28 1 Reference 95 1 Reference
> 0 50 13 10.38 3.18-33.84 11 1.15 0.53-2.50 50 1.62 1.01-2.60

Odds ratios are estimated from a polytomous logistic regression model adjusted for BMI, maternal age and nulliparity, with additional adjustment for gestational age.

PlGF: placental growth factor; s-Eng: soluble endoglin; sVEGFR-1: soluble vascular endothelial growth factor receptor-1; SGA: small for gestational age.